drugset / Trial / NCT00360568

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

NCT00360568 ↗

Phase 3 Completed 62 enrolled AbbVie Quintiles, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

Long term safety and efficacy (12 months) of levodopa-carbidopa intestinal gel.

Timeline

Start
2009-06
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa-carbidopa intestinal gel Unknown — Other